Sirui Tan

机构：Sichuan University, West China Hospital of Sichuan University, Sichuan Cancer Hospital, State Key Laboratory of Biotherapy, Southern Medical University

发表论文 15 篇 · 总被引 84 次 · h-index 6

代表论文

• The P2 purinoceptors in prostate cancer (2022 · Purinergic Signalling · 被引 16)
• Rare DNA Mismatch Repair-Related Protein Loss in Patients with Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma and Their Response to Immunotherapy (2021 · Cancer Management and Research · 被引 14)
• Efficacy and safety of fruquintinib dose‐escalation strategy for elderly patients with refractory metastatic colorectal cancer: A single‐arm, multicenter, phase II study (2023 · Cancer Medicine · 被引 11)
• PD-1 inhibitors plus nab-paclitaxel-containing chemotherapy for advanced gallbladder cancer in a second-line setting: A retrospective analysis of a case series (2022 · Frontiers in Oncology · 被引 11)
• 68Ga-FAPI-04 positron emission tomography/CT and laparoscopy for the diagnosis of occult peritoneal metastasis in newly diagnosed locally advanced gastric cancer: study protocol of a single-centre prospective cohort study (2024 · BMJ Open · 被引 8)
• Durable response to the combination of pembrolizumab and nab-paclitaxel in a metastatic extrahepatic cholangiocarcinoma: A case report and literature review (2022 · Frontiers in Pharmacology · 被引 6)